If you are an investor in Applied Therapeutics and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (212) ...

Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

A class action lawsuit was filed against Applied Therapeutics, Inc. (APLT) by Levi & Korsinsky on December 17, 2024. The ...

February 10, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both ...

Kuro Oncology and partner Kyowa Kirin are on track for an NDA submission for ziftomenib in the second quarter of this year.

Kirby McInerney LLP Alerts Applied Therapeutics, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit ...

Kirby McInerney LLP Urges Investors in Applied Therapeutics, Inc. (APLT) to Inquire About Their Rights in Class Action Lawsuit. Tweet ...

While stock investors are keeping expectations low from ... as it will be the first full-year budget of NDA’s new term. Based on a detailed analysis of NDA’s past two terms, it can be inferred ...

Investor, former GitHub CEO ... Will provide pizza. Have to sign NDA. Please DM." Thanks to the investigative reporting of my intrepid colleague Kyle, we know that he isn't kidding.

Investor, former GitHub CEO, and all around Tech Guy™ Nat Friedman has posted a strangely enticing offer on X. His post reads, “Need volunteers to come to my office in Palo Alto today to construct a ...